Scaling CRISPR For Rare Disease With Aurora Therapeutics' Dr. Edward Kaye In the News Mar 1 Written by Christine Mackenzie Christine Mackenzie Next Next Gene Editing Has Struggled To Go Commercial. This Nobel Laureate Has A $1 Billion Plan To Fix That.
Scaling CRISPR For Rare Disease With Aurora Therapeutics' Dr. Edward Kaye In the News Mar 1 Written by Christine Mackenzie Christine Mackenzie
